Безопасен ли oligopeptide-15 при беременности?

Related ingredients

Frequently asked questions

Безопасен ли oligopeptide-15 при беременности?

No evidence found of reproductive or developmental toxicity for oligopeptide-15 in available regulatory sources. There is no harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment flagging reproductive risk. Peptides of this type are generally large, enzymatically degraded and have low dermal/systemic bioavailability when used topically, supporting negligible exposure in pregnancy (sources searched: ECHA Annex VI, SCCS/CIR, PubChem, PubMed, CosIng, EWG).

Безопасен ли oligopeptide-15 при грудном вскармливании?

No data indicating maternal reproductive or lactation hazards or transfer into breast milk. No harmonised classification or safety assessment (ECHA Annex VI, SCCS, CIR). Topical peptides are typically poorly absorbed and rapidly metabolised, so systemic exposure sufficient for significant breast milk transfer is unlikely (sources searched: PubMed, PubChem, CosIng, EWG).

Безопасен ли oligopeptide-15 для кожи малыша?

No hazard or mechanism evidence specific to infants. However, infant skin has an immature barrier and higher surface-area-to-weight ratio; where an ingredient has any measurable dermal absorption in adults, exposure for 0–3 yr olds is typically increased. For oligopeptide-15 there are no reported reproductive/toxic findings, so hazard and mechanism are scored 0, but exposure is increased by +1 for baby skin precaution (sources searched: PubMed, PubChem, CosIng, EWG; no SCCS/CIR/ECHA harmonised concerns found).

Как VeriMom оценивает oligopeptide-15?

VeriMom оценивает oligopeptide-15 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы oligopeptide-15 при беременности?

См. наш список безопасных альтернатив oligopeptide-15 с аналогичной функцией и классификацией без известных рисков.